Table 2. EBV strains in healthy donors (HD) and EBV-associated gastric carcinoma in the Americas.
| EBNA | F/f variant | type C/D | XhoI kept/loss | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | F | f | C | D | kept | loss | ||||||||||||||
| References | Country | EBVaGC | HD | EBVaGC | HD | p value | EBVaGC | HD | EBVaGC | HD | p value | EBVaGC | HD | EBVaGC | HD | p value | EBVaGC | HD | EBVaGC | HD | p value |
| Herrera-Goepfert et al. (2005) | Mexico | 5 | ND | 0 | ND | ND | 5 | ND | 0 | ND | ND | 5 | ND | 0 | ND | ND | 1 | ND | 4 | ND | ND |
| Corvalán et al. (2006) | Colombia | 23 | 159 | 6 | 15 | 0.048176 | 29 | 100 | 0 | 8 | 0.046186 | 2 | 40 | 27 | 116 | 0.026917 | 25 | 115 | 4 | 55 | 0.043103 |
| Ordonez et al. (2011) | Peru | 0 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 5 | 101 | 6 | 17 | 0.00088 | 9 | 17 | 2 | 105 | 0 |
| Corvalán et al. (2006) | Chile | 36 | 98 | 5 | 7 | 0.27439 | 40 | 94 | 0 | 9 | 0.012438 | 0 | 45 | 35 | 54 | 0 | 35 | 19 | 0 | 45 | 0 |
| Consolidate | 64 | 257 | 11 | 22 | 0.072 | 74 | 194 | 0 | 17 | < 0.001 | 12 | 186 | 68 | 187 | < 0.001 | 70 | 151 | 10 | 160 | < 0.001 | |